Trial NCT00750698

View at ClinicalTrials.gov 
Org. Study IDs: SNDX-275-0403

Last trial update was posted on 2023-07-06

MeSH Interventions

Entinostat Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non Small Cell Lung Cancer

Stopping Reasons

Due to business reasons, enrollment on the study was halted and the study terminated. The decision to close enrollment was not due to any safety concern.

Limitations And Caveats

Due to business reasons, enrollment on the study was halted and the study terminated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID